ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
News– Researchers from Switzerland have announced the development of a gene-editing technique that may potentially aid in the treatment of Stargardt disease.
About Stargardt Disease
- It is a rare inherited genetic disorder that leads to progressive vision loss, especially in children and young adults.
- Cause: The disease is caused by mutations in the ABCA4 gene, which disrupts the body’s ability to process Vitamin A properly. This leads to the accumulation of lipofuscin, a fatty substance that builds up on the macula—the central part of the retina responsible for sharp, central vision.
- Bilateral: Stargardt disease typically affects both eyes (bilateral), resulting in the gradual loss of central visual acuity in both eyes.
- No Cure: There is currently no cure or effective treatment for Stargardt disease, though research continues to explore potential therapies.
